DexCom received a warning letter from the Food and Drug Administration following inspections of two of its plants.
Dexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” ...
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
Financial giants have made a conspicuous bearish move on DexCom. Our analysis of options history for DexCom (NASDAQ:DXCM) revealed 12 unusual trades. Delving into the details, we found 33% of ...
DexCom, Inc. DXCM reported fourth-quarter 2024 ... The broader S&P 500 Index has moved up 10% in the same period. Image Source: Zacks Investment Research Sensor and other revenues (96% of total ...